Use of micromolecular copper complexes of thiosemicarbazides as an endogenous catalase inducer/activator
pdf

Keywords

copper coordinating compound
thiosemicarbazide derivatives
production or activation of CAT
multifactorial diseases

How to Cite

Lilia ANDRONACHE, Valeriana PANTEA, Aurelian GULEA, Olga TAGADIUC, Valerii MATCOVSCHI and Valentin GUDUMAC (2024) “Use of micromolecular copper complexes of thiosemicarbazides as an endogenous catalase inducer/activator ”, One Health & Risk Management , pp. 117-123. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/732 (Accessed: 1July2025).

Abstract

Introduction. Oxidative stress is a major mechanism in the pathogenesis of many diseases, including severe multifactorial ones. Catalase (CAT), along with superoxide dismutase, is one of the first-line antioxidant defense enzymes. The development of methods/compounds that can increase/induce CAT will provide new possibilities to strengthen antioxidant protection and prevent oxidative damage to cells and tissues.

Material and methods. The ability of three copper coordination compounds from the class of transition metal thiosemicarbazides to enhance/induce CAT in erythrocytes of healthy white laboratory rats has been studied.

Results. Dichloro-(methyl-N-(prop-2n-1-yl)-2-(pyridin-2-ylmethylidene)hydrazine-carbimi do-thioate)copper was found to show the highest induction and/or activation of CAT, exceeding 2.71 times the values of the control group and 1.80 times the values produced by vitamin D3. This reveals increased synthesis of CAT after exposure to this compound, a phenomenon that we have established for the first time.

Conclusions. The compound can be used as a therapeutic agent, which, by activating the production of CAT in the body, can prevent and/or reduce the occurrence of multifactorial diseases, due to prevention of the damage of cells associated with excessive accumulation of hydrogen peroxide. The obtained data open perspectives for the research of biologically active synthetic compounds, which will diversify the arsenal of effective tools for preventing/treating various diseases.

pdf

|Views: 101| |pdf Downloads: 47|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370